Back to Search
PETER BALLARD, M.D.
M.D.
Emergency Medicine Physician
NPI: 1811378102IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
R1171(TX)2019-01753(NC)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia.
PMID 19151197·Am J Respir Crit Care Med·2009
7-preclinical
Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein.
PMID 19329538·Am J Physiol Lung Cell Mol Physiol·2009
8-other
Proteolytic activation of the cytotoxic phenotype during human NK cell development.
PMID 19570824·J Immunol·2009
8-other
Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18313293·Bioorg Med Chem Lett·2008
7-preclinical
One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial.
PMID 18534620·J Pediatr·2008
2-rct
Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia.
PMID 18500734·Pediatr Pulmonol·2008
4-observational
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
PMID 18182285·Bioorg Med Chem Lett·2008
7-preclinical
Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
PMID 18310205·Pediatrics·2008
2-rct
Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog.
PMID 18988082·Xenobiotica·2008
7-preclinical
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18061446·Bioorg Med Chem Lett·2008
7-preclinical
Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
PMID 17417700·Calcif Tissue Int·2007
2-rct
Surfactant function and composition in premature infants treated with inhaled nitric oxide.
PMID 17671061·Pediatrics·2007
4-observational
Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold.
PMID 17415785·J Orthop Res·2007
7-preclinical
Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.
PMID 17403837·Pediatrics·2007
4-observational
Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes.
PMID 16960125·Am J Respir Cell Mol Biol·2007
7-preclinical
Role of endogenous TGF-beta in glucocorticoid-induced lung type II cell differentiation.
PMID 16997883·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Developmental regulation of DUOX1 expression and function in human fetal lung epithelial cells.
PMID 17337509·Am J Physiol Lung Cell Mol Physiol·2007
8-other
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 17869514·Bioorg Med Chem Lett·2007
7-preclinical
Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
PMID 16870913·N Engl J Med·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MALVESTI ST
APO, AA 28310 - Phone
- (910) 907-6000
Quick Facts
- NPI
- 1811378102
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile